Production of Myco-Nanomaterial Products from Pleurotus ostreatus (Agaricomycetes) Mushroom via Pyrolysis.

IF 4.9 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Gréta Törős, Áron Béni, Andrea Kovács Balláné, Dávid Semsey, Aya Ferroudj, József Prokisch
{"title":"Production of Myco-Nanomaterial Products from <i>Pleurotus ostreatus</i> (Agaricomycetes) Mushroom via Pyrolysis.","authors":"Gréta Törős, Áron Béni, Andrea Kovács Balláné, Dávid Semsey, Aya Ferroudj, József Prokisch","doi":"10.3390/pharmaceutics17050591","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> The study aimed to develop a sustainable method for producing myco-nanomaterials, particularly fluorescent carbon nanodots (CNDs), from freeze-dried <i>Pleurotus ostreatus</i> (Agaricomycetes) mushroom powder via pyrolysis. The goal was to investigate how pyrolysis conditions affect CND characteristics and their potential antimicrobial properties. Mushroom powder was pyrolyzed at temperatures ranging from 150 to 240 °C. The resulting products were analyzed for yield, molecular weight, fluorescence intensity, and estimated CND concentration in relation to the carbon-to-nitrogen (C/N) ratio. Antibacterial activity was tested against <i>Escherichia coli</i> and <i>Staphylococcus epidermidis</i>. Product yield decreased from 13.20% at 150 °C to 0.80% at 240 °C. Molecular weight peaked at 200 °C (623.20 kDa), while maximum fluorescence intensity (739.40 A.U.) was observed at 210 °C. A strong positive correlation (R<sup>2</sup> = 0.72) was found between the C/N ratio and estimated CND concentration. Antimicrobial testing revealed notable inhibition of <i>E. coli,</i> associated with higher fluorescence intensity and CND content. Pyrolyzed <i>P. ostreatus</i> mushroom powder offers a promising, eco-friendly platform for producing luminescent, carbonaceous nanomaterials with antibacterial potential. These non-purified, myco-derived nanomaterials may contribute to green nanotechnology development and antimicrobial strategies.</p>","PeriodicalId":19894,"journal":{"name":"Pharmaceutics","volume":"17 5","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12114672/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/pharmaceutics17050591","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The study aimed to develop a sustainable method for producing myco-nanomaterials, particularly fluorescent carbon nanodots (CNDs), from freeze-dried Pleurotus ostreatus (Agaricomycetes) mushroom powder via pyrolysis. The goal was to investigate how pyrolysis conditions affect CND characteristics and their potential antimicrobial properties. Mushroom powder was pyrolyzed at temperatures ranging from 150 to 240 °C. The resulting products were analyzed for yield, molecular weight, fluorescence intensity, and estimated CND concentration in relation to the carbon-to-nitrogen (C/N) ratio. Antibacterial activity was tested against Escherichia coli and Staphylococcus epidermidis. Product yield decreased from 13.20% at 150 °C to 0.80% at 240 °C. Molecular weight peaked at 200 °C (623.20 kDa), while maximum fluorescence intensity (739.40 A.U.) was observed at 210 °C. A strong positive correlation (R2 = 0.72) was found between the C/N ratio and estimated CND concentration. Antimicrobial testing revealed notable inhibition of E. coli, associated with higher fluorescence intensity and CND content. Pyrolyzed P. ostreatus mushroom powder offers a promising, eco-friendly platform for producing luminescent, carbonaceous nanomaterials with antibacterial potential. These non-purified, myco-derived nanomaterials may contribute to green nanotechnology development and antimicrobial strategies.

以平菇(菌类)为原料热解制备纳米真菌产品。
背景:本研究旨在建立一种以冻干的平菇(Pleurotus ostreatus)蘑菇粉为原料,通过热解制备纳米真菌材料,特别是荧光碳纳米点(CNDs)的可持续方法。目的是研究热解条件如何影响CND特性及其潜在的抗菌性能。蘑菇粉在150 ~ 240℃的温度下进行热解。分析所得产物的产率、分子量、荧光强度和估计的CND浓度与碳氮比(C/N)的关系。对大肠杆菌和表皮葡萄球菌进行抑菌活性测定。产品收率从150℃时的13.20%下降到240℃时的0.80%。分子量在200°C时达到峰值(623.20 kDa),荧光强度在210°C时达到最大值(739.40 A.U.)。C/N比值与估算CND浓度呈显著正相关(R2 = 0.72)。抑菌试验结果表明,其对大肠杆菌有明显的抑制作用,且具有较高的荧光强度和CND含量。热解蘑菇粉末为生产具有抗菌潜力的发光碳质纳米材料提供了一个有前途的环保平台。这些未经纯化的、真菌衍生的纳米材料可能有助于绿色纳米技术的发展和抗菌策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmaceutics
Pharmaceutics Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
7.90
自引率
11.10%
发文量
2379
审稿时长
16.41 days
期刊介绍: Pharmaceutics (ISSN 1999-4923) is an open access journal which provides an advanced forum for the science and technology of pharmaceutics and biopharmaceutics. It publishes reviews, regular research papers, communications,  and short notes. Covered topics include pharmacokinetics, toxicokinetics, pharmacodynamics, pharmacogenetics and pharmacogenomics, and pharmaceutical formulation. Our aim is to encourage scientists to publish their experimental and theoretical details in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信